2020 Speakers
Leonela Amoasii, PhDDirector, Research Gene Editing, Exonics Therapeutics, Inc.
Brian Dougherty, PhD, MBAExecutive Director, Translational Science, Oncology IMED, AstraZeneca
Paul Yager, PhDProfessor, Bioengineering, University of Washington
Nathan Ledeboer, PhDProfessor and Vice Chair, Pathology and Medical Director, Medical College of Wisconsin
Duncan MacCannellCSO, Office of Advanced Molecular Detection, Centers for Disease Control and Prevention
Leidong Mao, PhDProfessor, School of Electrical and Computer Engineering, University of Georgia
Narasimha Marella, PhDDirector, Biomarker Operations, Loxo Oncology, Inc.
Ron Mazumder, PhD, MBAVice President, Oncology Biomarker Development & Companion Diagnostics, Genentech
Debra A. Patt, MDVP, Pfizer Oncology R&D
Ryan J. Sullivan, MDAssociate Director, Melanoma Program, MGH Cancer Center
Adrian Woolfson, BM, BCh, PhDExecutive Vice President, R&D, Sangamo Therapeutics
Ralph Graeser, PhDTransl. Medicine + Clin. Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG
Christopher M. Hartshorn, PhDPhD, Director, Cancer Treatment and Diagnosis, NCI
Michael LatauskaDirector, Digital Health, Boehringer Ingelheim
Raj PallapothuProfessor & Health Care Tech Industry Lead, University of Texas, Dallas
Joel SangermanChief Commercial Officer, Click Therapeutics, Inc.
Ben Busby, PhDComputational Biology Branch, NCBI, NLM, NIH
Atul Butte, MD, PhDChief Data Scientist, University of California Health (UC Health)
Massimo Saini, PhDPostdoctoral Researcher, Department of Biomedicine, University of Basel, Switzerland
Paul A. Rejto, PhDVP, Pfizer Oncology R&D
View All Speakers
Advancing Precision Medicine: Emerging Therapeutic, Diagnostic, and Technology Approaches
The International Molecular Medicine Tri-Conference, entering its 27th year, is the most comprehensive and leading industry events in the personalized medicine space today. The Tri-Conference brings together more than 3,100 innovative thinkers
and thought leaders in the field of drug discovery, development and diagnostics, informatics, and digital health throughout pharma, biotech, and academia. Through comprehensive educational programming, valuable networking opportunities, and an
expansive exhibit hall, event participants learn first-hand about the emerging developments and advancements of therapeutic, diagnostic, and technology approaches that are advancing precision medicine.